Advertisement

The Latest

Boston-based Dana-Farber Cancer Institute has received $50 million from the Yawkey Foundation to support the institute’s planned $1.7 billion cancer hospital, currently under construction. A bridge connecting the new hospital and Dana-Farber Cancer Institute’s Yawkey Center for Cancer Care will…

Nashville, Tenn.-based Vanderbilt Health and the University of Alabama at Birmingham have partnered to develop a genomic medicine consultation service. The initiative aims to improve access to genomic medicine in Alabama and Tennessee, according to a June 9 news release…

Tampa, Fla.-based Moffitt Cancer Center’s virtual care partnership with Reimagine Care has sustained patient engagement and symptom management during its initial implementation phase.   The platform has facilitated about 7,000 patient interactions, according to a May 20 news release from Reimagine…

Health system C-suites are under pressure from every direction: margin compression, workforce strain, fragmented technology and a pace of change that legacy operating models were never built to handle. This curated e-book brings together Becker’s reporting and industry thought leadership…

Presented by:

Presented by

The strongest predictor of colorectal cancer screening participation may be a specific, personalized communication from a patient’s own healthcare provider, according to a study led by researchers at Renton, Wash.-based Providence and published April 24 in Cancer Medicine. “We thought…

Boston-based Dana-Farber Cancer Institute has signed a letter of intent to build an ambulatory care building in Brighton, Mass.  Dana-Farber Cancer Institute President and CEO Benjamin Ebert, MD, PhD, shared news of the project in a June 8 LinkedIn post. …

City of Hope Chicago has appointed David Stewart, MD, chief of surgery. Dr. Stewart will also serve as medical director of surgical operations for all of City of Hope’s Illinois locations, according to a June 8 news release. He previously…

Outcome disparities among patients with multiple myeloma may be linked more closely to healthcare access than disease biology, according to Cleveland Clinic research presented at the American Society of Clinical Oncology’s annual meeting.  Researchers used data from the electronic health…

Deep learning AI models can analyze molecular and prognostic information found through routine pathology to predict tumor recurrence among patients with meningiomas, according to a study published June 5 in The Lancet Digital Health.  The models provide the same tumor…

Advertisement